Supernus Pharmaceuticals Inc (SUPN)
Long-Term Debt
$29.43M
Quarterly · Period ending: · USD
SUPN Long-Term Debt
Latest reported$29.43Mperiod ending
Latest reported$29.43Mperiod ending
SUPN Quarterly Long-Term Debt ($75.00M → $29.43M)
Quarterly long-term debt
High-resolution chart · PNG
SUPN long-term debt history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Long-Term Debt (USD) |
|---|---|
| 29,427,000 | |
| 30,267,000 | |
| 30,365,000 | |
| 31,422,000 | |
| 24,383,000 | |
| 26,368,000 | |
| 27,382,000 | |
| 28,926,000 | |
| 30,294,000 | |
| 32,994,000 | |
| 33,196,000 | |
| 33,841,000 | |
| 34,177,000 | |
| 36,511,000 | |
| 35,998,000 | |
| 36,028,000 | |
| 37,080,000 | |
| 440,273,000 | |
| 420,550,000 | |
| 412,049,000 | |
| 406,526,000 | |
| 413,069,000 | |
| 410,565,000 | |
| 406,332,000 | |
| 401,839,000 | |
| 380,036,000 | |
| 375,610,000 | |
| 368,419,000 | |
| 364,745,000 | |
| 361,134,000 | |
| 329,462,000 | |
| 325,666,000 | |
| 321,920,000 | |
| 318,225,000 | |
| 22,258,000 | |
| 22,702,000 | |
| 1,472,000 | |
| 3,310,000 | |
| 4,165,000 | |
| 5,772,000 | |
| 5,699,000 | |
| 5,627,000 | |
| 7,085,000 | |
| 8,068,000 | |
| 8,762,000 | |
| 11,708,000 | |
| 26,223,000 | |
| 26,497,000 | |
| 28,671,000 | |
| 28,358,000 | |
| 34,393,000 | |
| 60,175,000 | |
| 59,100,000 | |
| 7,975,000 | |
| 11,088,000 | |
| 14,116,000 | |
| 17,061,000 | |
| 18,625,000 | |
| 22,711,000 | |
| 86,008,000 | |
| 75,000,000 | |
| 75,000,000 | |
| 75,000,000 |